BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38590708)

  • 1. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.
    Marquard FE; Jücker M
    Biochem Pharmacol; 2020 Feb; 172():113729. PubMed ID: 31785230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSP90B1 regulates autophagy
    Li C; Lin X; Su J
    PeerJ; 2024; 12():e17028. PubMed ID: 38590708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway.
    Liu L; Sun YH; An R; Cheng RJ; Li N; Zheng JH
    Kaohsiung J Med Sci; 2023 Aug; 39(8):779-788. PubMed ID: 37218642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway.
    Liu P; Kong X; Yi S; Chen Y; Luo W
    World J Surg Oncol; 2024 Jan; 22(1):34. PubMed ID: 38273364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
    Feng B; Chen K; Zhang W; Zheng Q; He Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone.
    Santos LS; Silva VR; de Castro MVL; Dias RB; Valverde LF; Rocha CAG; Soares MBP; Quadros CA; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
    Cell Death Dis; 2023 Dec; 14(12):832. PubMed ID: 38102125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT.
    Li X; Wang G; Zhou X; Zhao H; Chen X; Cui Q; Li M; Gao X; Wei X; Ye L; Li D; Hong P
    Phytother Res; 2023 Oct; 37(10):4740-4754. PubMed ID: 37559472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma.
    Qiu B; Sun Y; Nie W; Yang Q; Guo X
    Immun Inflamm Dis; 2023 May; 11(5):e845. PubMed ID: 37249289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and autophagy-related pathways in cancer.
    Debnath J; Gammoh N; Ryan KM
    Nat Rev Mol Cell Biol; 2023 Aug; 24(8):560-575. PubMed ID: 36864290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manassantin A inhibits tumour growth under hypoxia through the activation of chaperone-mediated autophagy by modulating Hsp90 activity.
    Byun JK; Lee SH; Moon EJ; Park MH; Jang H; Weitzel DH; Kim HH; Basnet N; Kwon DY; Lee CT; Stephenson TN; Jeong JH; Patel BA; Park SJ; Chi JT; Dewhirst MW; Hong J; Lee YM
    Br J Cancer; 2023 Apr; 128(8):1491-1502. PubMed ID: 36759727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP90 mediates the connection of multiple programmed cell death in diseases.
    Peng C; Zhao F; Li H; Li L; Yang Y; Liu F
    Cell Death Dis; 2022 Nov; 13(11):929. PubMed ID: 36335088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology and inhibition of glucose-regulated protein 94/gp96.
    Pugh KW; Alnaed M; Brackett CM; Blagg BSJ
    Med Res Rev; 2022 Nov; 42(6):2007-2024. PubMed ID: 35861260
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.